Snow mountain virus genome sequence, virus-like particles and methods of use

Patent Citations (44)

Non-Patent Literature (139)

• Ball J. Virol. 1998, vol. 72, No. 2, pp. 1345-1353.Examiner
• Altschul et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Res. 25(17):3389-3402 (1997).Applicant
• Altschul et al., “Local Alignment Statistics” Methods in Enzymology 266:460-480 (1996).Applicant
• Altschul et al., “Basic Local Alignment Search Tool,” J.Mol.Biol. 403-410 (1990).Applicant
• Ando et al. “Comparison of the polymerase region of small round structured virus strains previously classified in three antigenic types by solid-phase immune electron microscopy” Arch Virol., 135(102):217-26 (1994).Applicant
• Baric et al., “Expression and Self-Assembly of Norwalk Virus Capsid Protein from Venezuelan Equine Encephalitis Virus Replicons,” J. Virol ; 76(6):3023-30 (Mar. 2002).Applicant
• Benson et al. “GenBank” Nucleic Acids Research , vol. 28, No. 1 (2000).Applicant
• Berge et al. “Pharmaceutical Salts” J. Pharm. Sci. 66:1-19 (1977).Applicant
• Bertolotti-Ciarlet et al., “Structural Requirements for the Assembly of Norwalk Virus-Like Particles,” J. Virol 76(8):4044-55 (Apr. 2002).Applicant
• Boerner et al., “Production of Antigen-Specific Human Monoclonal Antibodies from in vitro-primed Human Splenocytes,” J. Immunol. 147(1):B6-95 (1991).Applicant
• Boniotti et al., “Identification and Characterization of a 3C-Like Protease from Rabbit Hemorrhagic Disease Virus, a Calicivirus,” J. Virol. 68(10):6487-95 (Oct. 1994).Applicant
• Brill et al., “Synthesis of Oligodeoxynucleoside Phosphorodithioates via Thioamidites,” J.Am.Chem.Soc. 111:2321 (1989).Applicant
• Carlsson et al. “Screening for Genetic Mutations,” Nature 380:207(1996).Applicant
• Carter et al., “Humanization of an anti-p185HER2 antibody for human cancer therapy,” Proc. Natl. Acad. Sci. USA 89(10):4285-9 (1992).Applicant
• Chalfie, et al. “Green Fluorescent Protein as a Marker for Gene Expression,” Science 263 (5148):802-805 (Feb. 11, 1994).Applicant
• Clarke et al., “Organization and Expression of Calicivirus Genes,” J. Infect. Dis. 181 Suppl. 2:S309-16 (2000).Applicant
• Dedman et al., “Surveillance of small round structured virus (SRSV) infection in England and Wales, 1990-5,” Epidomiol. Infect. 121(1):139-149 (1998).Applicant
• Dempcy et al., “Synthesis of a thymidyl pentamer of deoxyribonucleic guanidine and binding studies with DNA homopolynucleotides,” Proc. Natl. Acad. Sci. USA 92(3):6097(1995).Applicant
• Dingle et al. “Human enteric Calicviridae: the complete genome sequence and expression of virus-like particles from a genetic group II small round structured virus” J.Gen Virol. 76(Pt.9):2349-55 (Sep. 1995).Applicant
• Dolin et al. “Detection by Immune Electron Microscopy of the Snow Mountain Agent of Acute Viral Gastroenterities,” J. Infect Dis. 146(2):184-9 (Aug. 1982).Applicant
• Duggal et al., “Genetic recombination of a poliovirus in a cell-free system,” Proc Natl Acad Sci USA 94(25):13786-91 (Dec. 1997).Applicant
• Duggal et al., “Genetic Recombination of Poliovirus in Vitro and in Vivo: Temperature-Dependent Alteration of Crossover Sites,” Virology 25:258(1):30-41 (May 1999).Applicant
• Dunham et al., “Genomic mapping of a calicivirus VPg,” Arch Virol 143(12):2421-30 (1998).Applicant
• Egholm et al., “Peptide Nucleic Acids (PNA). Oligonucleotide Analogues with an Achiral Peptide Backbone,” J.Am.Chem.Soc. 114:1895 (1992).Applicant
• Egholm, et al., “PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen bonding rules,” Nature 365:566-568 (1993).Applicant
• Epub Jan. 3, 2002.Applicant
• Evan et al., “Isolation of Monoclonal Antibodies Specific for Human c-myc Proto-Oncogene Product,” Molecular and Cellular Biology 5:3610-3616 (1985).Applicant
• Fankhauser et al., “Molecular Epidemiology of “Norwalk-like Virues” in Outbreaks of Gastroenteritis in the United States,” J. Infect. Dis. 178(6):1751-1578 (1998).Applicant
• Feng and Doolittle, “Progressive Sequence Alignment as a Prerequisite to Correct Phylogenetic Trees,” J.Mol. Evol. 25(4):351-360 (1987).Applicant
• Field et al., “Purification of RAS-Responsive Adenylyl Cyclase Complex from Saccharomyces cervisiae by Use of an Epitope Addition Method,” Mol. Cell. Biol., 8:2159-2165(1988).Applicant
• Fishwild et al. “High-avidity human IgGk monoclonal antibodies from a novel strain of minilocus transgenic mice” Nature Biotechnology 7:845-51 (1996).Applicant
• Gao et al. “Unusual conformation of a 3′-thioformacetal linkage in a DNA duplex” J. Biomolecular NMR 4(1):17-34 (1994).Applicant
• Glass et al., “Norwalk Virus Open Reading Frame 3 Encodes a Minor Structural Protein,” J. Virol. 74(14):6581-91(Jul. 2000).Applicant
• Green et al., “A Predominant Role for Norwalk-like Viruses as Agents of Epidemic Gastroenteritis in Maryland Nursing homes for the Elderly,” J. Infect Dis. 185(2):133-46 (Jan. 15, 2002).Applicant
• Green et al., “Capsid Protein Diversity among Norwalk-like Viruses,” Virus Genes 20(3):227-36 (2000).Applicant
• Green et al., “Expression and Self-Assembly of Recombinant Capsid protein from the Antigenically Disticnt Hawaii Human Calicivirus,” J. Clin. Microbiol. 35(7):1909-14 (Jul. 1997).Applicant
• Guo et al., “Molecular Characterization of a Porcine Enteric Calicivirus Genetically Related to Sapporo-Like Human Caliciviruses,” J. Virol. 73(11):9625-31 (Nov. 1999).Applicant
• Hale et al. “Expression and Self-Assembly of Grimsby Virus: Antigenic Distinction from Norwalk and Mexico Viruses,” Clin Diagn. Lab Immunol. 6(1):142-5 (Jan. 1999).Applicant
• Hardy et al. “Specific Proteolytic Cleavage of Recombinant Norwalk Virus Capsid Protein” Virus Genes 26(1):71-82, (2003).Applicant
• Hardy et al. “Human Calicivirus Genogroup II Capsid Sequence Diversity Revealed by Analyses of the Prototype Snow Mountain Agent,” Arch Virol. 142(7):1469-79 (1997).Applicant
• Hardy et al., “Specific Proteolytic Cleavage of Recombinant Norwalk Virus Capsid Protein,” J. Virol. 69(3); 145:1693-8 (Mar. 1995).Applicant
• Hardy et al., “Substrate specificity of the Norwalk virus 3c-like proteinase,” Virus Res. 89(1):29-39 (Oct. 2002).Applicant
• Hardy et al., “Completion of the Norwalk Virus Genome Sequence,” Virus Genes 12(3):287-90 (1996).Applicant
• Harrington et al., “Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated Mice,” J. Virol. 76(23):12335-12343 (2002).Applicant
• Heim, et al., “Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescent resonance energy transfer,” Curr.Biol. 6(2):178-182 (1996).Applicant
• Hest et al., “Efficient introduction of aldene functionality into proteins in vivo,” FEBS Lett. 428(1-2):68-70 (1998).Applicant
• Higgins and Sharp, “Fast and Sensitive Multiple Sequence Alignments on a Microcomputer,” CABIOS 5:151:153 (1989).Applicant
• Hoogenboom and Winter, “By-passing Immunisation Human Antibodies from Synthetic Repertoires of Germline VH Gene Segments Rearranged in Vitro,” J Mol. Biol. 227(2):381-388 (1992).Applicant
• Hopp et al. Bio Technology 6:1204-1210(1988).Applicant
• Hora et al. Bio/Technology 8:755-758 (1990).Applicant
• Horn et al., “Oligonucleotides with Alternating Anionic and Cationic Phosphoramidate Linkages: Synthesis and Hybridization of Stero-uniform Isomers,” Tetrahedron Lett. 37(6):743-746 (1996).Applicant
• Ichiki et al., “Regulation of the Expression of Human Cε Germline Transcript,” J. Immunol. 150 (12):5408-5417 (1993).Applicant
• Jenkins et al., “The Biosynthesis of Carbocyclic Nucleosides,” Chem. Soc. Rev. 169-176, (1995).Applicant
• Jiang et al., “Characterization of a novel human calicivirus that may be a naturally occuring recombinant,” Arch Virol 144(12):2377-87 (1999).Applicant
• Jiang et al., “Expression and characterization of Sapporo-like human calicivirus capsid proteins in baculovirus,” J. Virol Methods. 78 (1-2):81-91 (Mar. 1999).Applicant
• Jiang et al., “Expression, Self-Assembly, and Antigenicity of a Snow Mountain Agent-Like Calicivirus Capsid Protein,” J. Clin Microbiol. 33(6):1452-5 (Jun. 1995).Applicant
• Jiang et al., “Sequence and Genomic Organization of Norwalk Virus,” Virology 195(1):51-61 (Jul. 1993).Applicant
• Johnson et al., “A month-long effect from a single injection of microencapsulated human growth hormone” Nat. Med., 2:795-799 (1966).Applicant
• Jones et al., “Replacing the complementary-determining regions in a human antibody with those from a mouse,” Nature 321:522-525 (1986).Applicant
• Jung et al. et al. “Hybridization of Alternating Cationic/Anionic Oligonucleotides to RNA Segments” Nucleoside & Nucleotide 13:1597 (1994).Applicant
• Karlin et al., “Applications and statistics for multiple high-scoring segments in molecular sequences,” Proc. Natl. Acad. Sci. USA 90:5873-5787(1993).Applicant
• Kiedrowshi et al., Angew Chem. Intl. English 30:423 (1991).Applicant
• King et al., “Sequence Analysis of the Gene Encoding the Capsid Protein of the Snow Mountain Human Calicivisur,” Virus Genes. 15(1):5-7 (1997).Applicant
• Kirkegaard et al., “The Mechanism of RNA Recombinant in Poliovirus,” Cell 47(3):433-43 (Nov. 7, 1986).Applicant
• Kitamoto, N. et al., “Cross-Reactivity among Several Recombinant Calicivirus Lirus-Like Particles (VLPs) with Monoclonal Antibodies Obtained from Mice Immunized Orally with One Type of VLP,” J. Clin Microbiol., 40(7):2459-2465 (2002).Applicant
• Kohler and Milstein, “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity,” Nature 256:495-7(1975).Applicant
• Koopmans et al., “Molecular Epidemiolosy of Human Enteric Caliciviruses in the Netherlands,” J. Infect. Dis. 181 Suppl. 2:S262-69 (2000).Applicant
• Kozak, “Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes,” Nucleic Acids Res. 24;9(20):5233-52 (Oct. 1981).Applicant
• Lambden et al. “Sequence and Genome Organization of a Human Small Round-Structured (Norwalk-like) Virus” Science 22;259(5094):516-9 (Jan. 1993).Applicant
• Laurent et al., “Recombinant Rabbit Hemorrhagic Disease Virus Capsid Protein Expressed in Baculovirus Self-Assembles into Viruslike Particles and Induces Protection,” J. Virol. 68(10):6794-8 (Oct. 1994).Applicant
• Leite et al. “Characterization of Toronto Virus Capsid Protein Expressed in baculovirus,” Arch Virol. 141(5):865-75 (1996).Applicant
• Letsinger et al., “Cationic Oligonucleotides,” J. Am. Chem. Soc. 110:4470 (1988).Applicant
• Letsinger et al., “Effects of pendant groups at phosphorous on binding properties of d-ApA analogues,” Nucl. Acids. Res. 14:3487 (1986).Applicant
• Letsinger, “Phosphoramidate Analogs of Oligonucleotides,” J. Org. Chem. 35(11):3800 (1970).Applicant
• Lew et al. “Molecular characterization of Hawaii virus and other Norwalk-like viruses: evidence for genetic polymorphism among human caliciviruses,” J. Infect Dis. 170(3):535-42 (Sep. 1994).Applicant
• Liu et al., “Identification of further proteolytytic cleavage sites in the Southampton calicivirus polyprotein by expression of the viral protease in E. coli,” J. Virol. 80(Pt2):291-6 (Feb. 1999).Applicant
• Liu et al., “Polyprotein Processing in Southampton Virus: Identification of 3C-Like protease Cleavage Sites by in Vitro Mutagenesis,” J. Virol. 70(4):2605-10 (Apr. 1996).Applicant
• Lizardi et al., “Mutation detection and single-molecule counting using isothermal rolling-circle amplification,” Nat. Genetics 19 (3):225-232 (1998).Applicant
• Lochridge, V. et al., “Snow Mountain Virus Genome Sequence and Virus-like Particle Assembly,” Virus Genes, 26(1): 71-82 (2003).Applicant
• Lonberg and Huszar, “Human antibodies from transgenic mice,” Intern. Rev. Immunol. 13(1):65-93 (1995).Applicant
• Lonberg et al., “Antigen-specific human antibodies from mice comprising four distinct genetic modifications,” Nature 368:856-859 (1994).Applicant
• Lutz-Freyermuth et al., “Quantitative determination that one of two potential RNA-binding domains of the A protein component of the U1 small nuclear ribonucleoprotein complex binds with high affinity to stem-loop II of U1 RNA,” Proc. Natl. Acad. Sci. USA 87:6393-6397 (1990).Applicant
• Mag et al., “Sythesis and selective cleavage of an oligodeoxynucleotide containing a bridged internucleotide 5′-phosphorothioate linkage,” Nucleic Acids Res. 19:1437 (1991).Applicant
• Marin et al., “ATP Binding and ATPase Activities Associated with Recombinant Rabbit Hemorrhagic Disease Virus 2C-Like Polypeptide,” J. Virol. 74(22):10846-51 (Nov. 2000).Applicant
• Marks et al. “By-passing immunization: building high affinity human antibodies by chain shuffling,” Biotechnology 10:779-783 (1992).Applicant
• Marks et al., “By-Passing Immunization: Human Antibodies from V-gene Libraries Displayed on Phage,” J. Mol. Biol. 222(3):581 (1991).Applicant
• Martin et al., “GAP Domains Responsible for Ras p21-Dependnatn Inhibition of Muscarinic Atrial K+ Channel Currents,” Science 255:192-194 (1992).Applicant
• Mathews et al. “Expanded Sequence Dependence of Thermodynamic Parameters Improves Prediction of RNA Secondary Structure” J.Mol. Biol. 21;288(5):911-40 (May 1999).Applicant
• Meier et al. “Peptide Nucleic Acids (PNAs)—Unusual Properties of Noniomic Oligonucleotide Analogues,” Chem. Int. Ed. Eng. 31:1008-10 (1992).Applicant
• Mendez et al., “A comparative analysis of Freon substitutes in the purification of reovirus and calicivirus,” J. Virol Methods 90(1):59-67 (Oct. 2000).Applicant
• Mesmaeker et al., “Comparison of Rigid and Flexible Backbones in Antisense Oligonucleotides,” Bioorganic & Medicinal Chem. Lett. 4:395 (1994).Applicant
• Morens et al. “A waterbone outbreak of gastroenteritis with secondary person-to-person spread. Association with a viral agent,” Lancet 1(8123):964-6 (May 5, 1979).Applicant
• Morrison, “Success in Specification,” Nature 368:812-13 (1994).Applicant
• Nadeau et al., “Real-Time, Sequence-Specific Detection of Nucleic Acids during Strand Displacement Amplification,” Anal. Biochem 276(2):177-187 (1999).Applicant
• Nagy et al., “Dissecting RNA recombinant in vitro: role of RNA sequences and the viral replicase,” EMBO J. 17(8):2392-403 (Apr. 15, 1998).Applicant
• Nagy et al., “In Vitro Characterization of Late Step of RNA Recombination in Turnip Crinkle Virus,” Virology 249(2):393-405 (Sep. 30, 1998).Applicant
• Nagy et al., “In Vitro Characterization of Late Steps of RNA Recombinant in Turnip Crinkle Virus,” Virology 249(2):379-92 (Sep. 30, 1998).Applicant
• Nagy et al., “New Insights into the Mechanisms of RNA Recombination,” Virology 235(1):1-9 (Aug. 18, 1997).Applicant
• Nagy et al., “RNA elements required for RNA recombinant function as replication enhancers in vitro and in vivo in a plus-strand RNA virus,” EMBO J. 18(20):5653-65 (Oct. 15, 1999).Applicant
• Needleman & Wunsch, “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins,” J. Mol. Biol. 48(3):433-453 (1970).Applicant
• Neill, “Nucleotide sequence of the capsid protein gene of two serotypes of San Miguel sea lion virus: Identification of conserved and non-conserved amino acid sequences among calicivirus capsid proteins,” Virus Res 24(2):211-22 (Jul. 1992).Applicant
• Neuberger “Generating high-avidity human Mabs in Mice” Nature Biotechnology 14:826 (1996).Applicant
• Noel et al., “Identification of a Distinct Common Strain of ‘Norwalk-like Viruses’ Having a Global Distribution,” J. Infect. Dis. 179(6):1334-1344 (1999).Applicant
• Nolan et al., “Fluorescence-activates cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of Escherichia coli lacZ,” Proc. Natl. Acad. Sci USA 85(8):2603-2607 (Apr. 1988).Applicant
• O'Connor et al., “Humanization of an antibody against human protein C and calcium-dependance involving framework residues,” Protein Eng. 11:321-8 (1998).Applicant
• Oggioni et al. “Protocol for Real-Time PCR Identification of Anthrax Spores from Nasal Swabs after Broth Enrichment” J. Clinical Microbiol., 3956-3963 (Nov. 2002).Applicant
• Paborsky et al. “Mammalian cell transient expression of tissue factor for the production of antigen” Protein Engineering 3(6):547-553 (1990).Applicant
• Pauwels et al. “Biological Activity of New 2-5A Analogues” Chemica Scripta 26:1419 (1986).Applicant
• Pearson and Lipman, Improved tools for biological sequence Proc. Natl. Acad. Sci. USA 85:2444 (1988).Applicant
• Pfister et al., “Polypeptide p41 of a Norwalk-Like Virus Is a Nucleic Acid-Independent Nucleoside Triphosphatese,” J. Virol 75(4):1611-9 (Feb. 2001).Applicant
• Pletneva et al., “The Genome of Hawaii Virus and its Relationship with other Members of the Caliciviridae,” Virus Genes. 23(1):5-16 (2001).Applicant
• Prasad et al. “X-ray Crystallographic Structure of the Norwalk Virus Capsid,” Science 8;286(5438):287-90 (Oct. 1999).Applicant
• Presta, “Antibody Engineering” Curr. Op. Struct. Biol. 2:593-596 (1992).Applicant
• Queen et al., “A humanized antibody that binds to the interleukin 2 receptor,” Proc. Natl. Sci. USA 86:10029-33 (1989).Applicant
• Riechmann et al., “Reshaping human antibodies for therapy,” Nature 332:323-329 (1988).Applicant
• Sawai et al. “Synthesis and Properties of Oligodenylic Acids Containing 2′-5′ Phosphoramide Linkage” Chem. Lett. 805 (1984).Applicant
• Schreier et al., “Molecular epidemiology of outbreaks of gastroenteritis associated with small round structured viruses in Germany in 1997/98,” Arch Virol. 145(3):443-53 (2000).Applicant
• Seah et al., “Open Reading Frame 1 of the Norwalk-Like Virus Camberwell: Completion of Sequence and Expression in Mammalian Cells,” J. Virol. 73(12):10531-5 (Dec. 1999).Applicant
• Seah et al., “Variation in ORF3 of genogroup 2 Norwalk-like viruses,” Arch Virol. 144(5):1007-14 (1999).Applicant
• Siepel et al., “A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences,” AIDS Res Hum Retroviruses 11(11):1412-6 (Nov. 1995).Applicant
• Simon et al., “Peptoids: A modular approach to drug discovery,” PNAS USA 89(20):9367 (1992).Applicant
• Skinner et al., “Use of the Glu-Glu-Phe C-terminal Epitope for Rapid Purification of the Catalytic Domain of Normal and Mutant ras GTPase- activating Proteins,” J.Biol.Chem. 266(22):14163-14166 (1991).Applicant
• Smith and Waterman, “Comparison of Biosequences,” Adv. Appl. Math. 2:482 (1981).Applicant
• Someya et al., “Complete Nucleotide Sequence of the Chiba Virus Genome and Functional Expression of the 3C-Like Protease in Escherichia coli,” Virology 278(2):490-500 (Dec. 20, 2000).Applicant
• Sosnovtsev et al., “Cleavage of the Feline Calicivirus Capsid Precursor is Mediated by a Virus-Encoded Proteinase,” J. Virol 72(4):3051-9 (Apr. 1998).Applicant
• Sosnovtsev et al., “Identification and Genomic Mapping of the ORF3 and VPg Proteins in Feline Calicivirus Virions,” Virology 277(1):193-203 (Nov. 10, 2000).Applicant
• Sprinzl et al., “Enzymatic Incorporation of ATP and CTP Analogues into the 3′End of tRNA,” Eur. J. Biochem 81(3):579-589 (1977).Applicant
• Stauber, R.H., “Development and applications of enhanced green fluorescent protein mutants,” Biotechniques 24(3):462-471 (1998).Applicant
• Stein, “Overcoming obstacles to monoclonal antibody product development and approval,” Trends in Biotechnol. 15(3):88-90 (1997).Applicant
• Tang et al. Abstr. Pap. Am. Chem. S218:U138 Part 2 (Aug. 22, 1999).Applicant
• Thompson et al., “Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice,” Nucleic Acids Res. 22(22):4673-80 (1994).Applicant
• Vazquez et al., “Expression of Enzymatically Active: Rabbit Hemorrhagic Disease Virus RNA-Dependent RNA Polymerase in Escherichia coli,” J. Virol. 72(4):2999-3004 (Apr. 1998).Applicant
• Verhoeyen et al. “Reshaping human antibodies: grafting an antilysozyme activity” Science 239:1534-1536 (1998).Applicant
• Vinge et al., “Genetic polymorphism across regions of the three open reading frames of ;Norwalk-like viruses,” Arch Virol. 145(2):223-41 (2000).Applicant
• Walker et al., “Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system,” PNAS 89:392-396 (1992).Applicant
• Walker et al., “Strand displacement amplification-an isothermal, in vitro DNA amplification technique,” Nucl. Acids. Res. 20 (7):1691-1696 (1992).Applicant
• Wang et. al., “Sequence Diversity of Small, round-Structured Viruses in the Norwalk Virus Goup,” J. Virol. 68(9):5982-90 (1994).Applicant
• Wirblich et al., “3C-Like Protese if Rabbit Hemorrhagic Disease Virus: Identification of Cleavage Sites in the ORF1 Polyprotein and Analysis of Cleavage Specificity,” J. Virol 69(11):7159-68 (1995).Applicant
• Wirblich et al., “Genetic Map of the Calicivirus Rabbit hemorrhagid Disease Virus as Deduced from in Vitro Translation Studies,” J. Virol. 70(11):7974-83 (1996).Applicant